THERAVANCE BIOPHARMA (TBPH) — News & AI sentiment

THERAVANCE BIOPHARMA (TBPH) news roundup. 3 stories aggregated over the last 30 days. Average 30-day sentiment is 58.7/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $6.1M — net selling of $6.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.